2024 annual financial data
Prelude Therapeutics 2024 Operating margin
Prelude Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -1,995.91%.
Operating income was -139,714,000 USD and net income was -127,173,000 USD.
Operating cash flow was -102,888,000 USD.
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,000,000 USD
- Operating income
- -139,714,000 USD
- Net income
- -127,173,000 USD
- Operating cash flow
- -102,888,000 USD